Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1).

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Virology

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2018.03.001PMID 29549787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global epidemiology and burden of HCV infection and HCV-related disease

  2017cited by this paper
• The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome

  2017cited by this paper
• Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.

  2017cited by this paper
• Hepatitis C viral load, genotype, and increased risk of developing end‐stage renal disease: REVEAL‐HCV study

  2017cited by this paper
• Hepatitis C virus infection

  2017cited by this paper
• Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy.

  2017cited by this paper
• Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.

  2017cited by this paper
• Cross-border spread, lineage displacement and evolutionary rate estimation of rabies virus in Yunnan Province, China

  2017cited by this paper
• Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors

  2017cited by this paper
• Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.

  2016cited by this paper
• Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents

  2016cited by this paper
• Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.

  2016cited by this paper
• Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir.

  2016cited by this paper
• Conserved RNA secondary structures and long-range interactions in hepatitis C viruses

  2015cited by this paper
• SEC14L2 enables pan-genotype HCV replication in cell culture

  2015cited by this paper
• hnRNP L and NF90 Interact with Hepatitis C Virus 5′-Terminal Untranslated RNA and Promote Efficient Replication

  2014cited by this paper
• Development of hepatitis C virus genotype 3a cell culture system

  2014cited by this paper
• Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.

  2014cited by this paper
• Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors

  2014cited by this paper
• Efficient Infectious Cell Culture Systems of the Hepatitis C Virus (HCV) Prototype Strains HCV-1 and H77

  2014cited by this paper
• Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors

  2014cited by this paper
• Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation

  2014cited by this paper
• Construction and characterization of infectious hepatitis C virus chimera containing structural proteins directly from genotype 1b clinical isolates.

  2013cited by this paper
• The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122

  2013cited by this paper
• End-to-end crosstalk within the hepatitis C virus genome mediates the conformational switch of the 3′X-tail region

  2013cited by this paper
• Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

  2013cited by this paper
• Hepatitis C virus RNA: molecular switches mediated by long-range RNA–RNA interactions?

  2012cited by this paper
• Regulation of Hepatitis C virus replication and gene expression by the MAPK-ERK pathway

  2012cited by this paper
• The folding of the hepatitis C virus internal ribosome entry site depends on the 3′-end of the viral genome

  2012cited by this paper
• Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site‐directed mutagenesis of an NS4B aminoterminal basic leucine zipper

  2012cited by this paper
• Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system

  2012cited by this paper
• Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains

  2012cited by this paper
• The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation

  2011cited by this paper
• Biochemical Study of the Comparative Inhibition of Hepatitis C Virus RNA Polymerase by VX-222 and Filibuvir

  2011cited by this paper
• Characterization of Resistance to the Nonnucleoside NS5B Inhibitor Filibuvir in Hepatitis C Virus-Infected Patients

  2011cited by this paper
• Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.

  2011cited by this paper
• Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 Core-Nonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 NS5A

  2011cited by this paper
• Non-genotype-specific role of the hepatitis C virus 5' untranslated region in virus production and in inhibition by interferon.

  2011cited by this paper
• Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.

  2011cited by this paper
• MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR

  2011cited by this paper
• Poly(C)-Binding Protein 2 Interacts with Sequences Required for Viral Replication in the Hepatitis C Virus (HCV) 5′ Untranslated Region and Directs HCV RNA Replication through Circularizing the Viral Genome

  2011cited by this paper
• Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

  2010cited by this paper
• Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.

  2010cited by this paper
• Genome cyclization as strategy for flavivirus RNA replication.

  2009cited by this paper
• Development and characterization of hepatitis C virus genotype 1‐7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

  2009cited by this paper
• A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome.

  2009cited by this paper
• Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

  2008cited by this paper
• Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.

  2008cited by this paper
• microRNA-122 stimulates translation of hepatitis C virus RNA

  2008cited by this paper
• Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus

  2008cited by this paper
• Regulation of hepatitis C virus by microRNA-122.

  2008cited by this paper
• A Hepatitis C Virus cis-Acting Replication Element Forms a Long-Range RNA-RNA Interaction with Upstream RNA Sequences in NS5B

  2008cited by this paper
• Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.

  2007cited by this paper
• Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras

  2007cited by this paper
• Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

  2007cited by this paper
• Replication of hepatitis C virus

  2007cited by this paper
• Hepatitis C Virus Subgenomic Replicon Requires an Active NS3 RNA Helicase

  2006cited by this paper
• The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

  2006cited by this paper
• Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

  2006cited by this paper
• Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA

  2005cited by this paper
• Robust hepatitis C virus infection in vitro.

  2005cited by this paper
• Complete Replication of Hepatitis C Virus in Cell Culture

  2005cited by this paper
• Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

  2005cited by this paper
• Evolution of naturally occurring 5' non-translated region variants of hepatitis C virus genotype 1b in selectable replicons.

  2004cited by this paper
• Long-range RNA-RNA interaction between the 5' nontranslated region and the core-coding sequences of hepatitis C virus modulates the IRES-dependent translation.

  2003cited by this paper
• Role of the 5′-Proximal Stem-Loop Structure of the 5′ Untranslated Region in Replication and Translation of Hepatitis C Virus RNA

  2003cited by this paper
• Analysis of hepatitis C virus/classical swine fever virus chimeric 5'NTRs: sequences within the hepatitis C virus IRES are required for viral RNA replication.

  2003cited by this paper
• Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication

  2002cited by this paper
• Interferon‐γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs

  2002cited by this paper
• Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.

  2002cited by this paper
• Domains I and II in the 5' nontranslated region of the HCV genome are required for RNA replication.

  2002cited by this paper
• Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA Replication

  2001cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000cited by this paper
• Natural Variation in Translational Activities of the 5′ Nontranslated RNAs of Hepatitis C Virus Genotypes 1a and 1b: Evidence for a Long-Range RNA-RNA Interaction outside of the Internal Ribosomal Entry Site

  1999cited by this paper
• Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line

  1999cited by this paper
• Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

  1999cited by this paper
• Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.

  1996cited by this paper

• Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance

  2023cites this paper
• Role of SEC14-like phosphatidylinositol transfer proteins in membrane identity and dynamics

  2023cites this paper
• Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection.

  2023cites this paper
• A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo

  2022influential citation
• Identification of a novel replication-competent hepatitis C virus variant that confers the sofosbuvir resistance.

  2021cites this paper
• Development of cell culture infectious clones for hepatitis C virus genotype 1b and transcription analysis of 1b-infected hepatoma cells.

  2021cites this paper
• Construction and characterization of Genotype-3 hepatitis C virus replicon revealed critical genotype-3-specific polymorphism for drug resistance and viral fitness.

  2019cites this paper
• Current status and future development of infectious cell‐culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies

  2018influential citation
• Development of an Infectious Cell Culture System for Hepatitis C Virus Genotype 6a Clinical Isolate Using a Novel Strategy and Its Sensitivity to Direct-Acting Antivirals

  2018cites this paper
• Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement

  2018cites this paper